Prospects of FEV6 using as alternative indicator of respiratory function assessment
DOI:
https://doi.org/10.14739/2310-1210.2017.5.110106Keywords:
chronic obstructive pulmonary disease, forced expiratory volume, forced vital capacityAbstract
The aim of the study was to establish a correlation between the changes of external respiratory function leading indicators in patients with COPD and the presence of a positive response to the bronchodilator over an extended period of observation and the value of the FEV6 index in assessment of bronchial obstruction reversibility.
Materials and methods. The study included 29 patients with confirmed diagnosis of COPD with II and III degree of ventilation disorders according to the GOLD classification and an increase in FEV1 more than 200 ml (12 %) when carrying out a test with a bronchodilator. With the help of the patients’ spirograms retrospective analysis over the long period of observation an evaluation and comparison of the external respiration function parameters was performed: FVC, FEV1 and FEV6.
Results. All patients were divided into 2 groups: group I included patients with a moderate degree of ventilation disorders severity by GOLD, group II – with severe impairment of external respiratory function. A reliable direct correlation between increments of FEV1 and FEV6, FVC and FEV6 (p < 0.05) was confirmed, which indicates a logical increase in FEV6 increment in parallel with the increase of FVC and FEV1 increments. When comparing the increase in FEV1 and FEV6 in group I it also was not noted significant differences. However, in group II FEV6 increment is two times higher than FEV1 increment with high probability (p < 0.05), which may be caused by the presence of more severe obstruction and longer expiration.
Conclusions. It has been found a significant positive correlation of FEV6 with FEV1 and FVC and significant relationship between the FEV6 and FVC increments in both study groups, between the FEV6 and FEV1 increments in the group with grade III ventilation disorders by GOLD classification. Thus, FEV6 can be considered as a perspective indicator of the external respiration function evaluation, especially in patients with more severe course of the disease.
References
Mostovoy, Yu. M., & Vishnivetsky, I. I. (2013). Rol' izucheniya obratimosti obstrukcii pri bronkhial'noj astme i khronicheskom obstruktivnom zabolevanii legkikh: obzor literatury i sobstvennyye dannye [Bronchodilator reversibility in bronchial asthma and chronic obstructive pulmonary disease: literature review and own data]. Ukrainskyi pulmonolohichnyi zhurnal, 7, 57–62. [in Russian].
(2013) Nakaz Ministerstva okhorony zdorovia Ukrainy «Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry khronichnomu obstruktyvnomu zakhvoriuvanni lehen» vid 27 chervnia 2013 roku №555 [Order of the Ministry of Health of Ukraine On approval and introduction of medical and technological documents for standardization of care in chronic obstructive pulmonary disease from June 27 2013, №555]. Kyiv. [in Ukrainian].
Feshchenko, O. I., Chaikovskyi, Yu. B., & Ostrovskyi, M. M., et al. (2016) Khronichne obstruktyvne zakhvoriuvannia legen: novi vidtinky khvoroby [Chronic obstructive pulmonary disease: new shades of the disease]. Ivano-Frankivsk. [in Ukrainian].
Akpinar-Elci, M., Fedan, K. B., & Enright, P. L. (2006). FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J, 27, 374–377. doi: 10.1183/09031936.06.00081305.
Brusasco, V., Crapo, R., & G. Viegi (Eds) (2005). Series “ATS/ERS Task Force: Standardisation of Lung Function Testing”. Standardisation of spirometry. Eur Respir J., 26, 319–338. doi: 10.1183/09031936.05.00034805.
(2016) Global initiative for chronic obstructive lung disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Retrieved from http://www.goldcopd.org/uploads/users/files/GOLD_Report%202016.pdf
Kainu, A., Lindqvist, A., Sarna, S., Lundbäck, B., & Sovijärvi, A. (2009). Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population. Respiratory Research, 10, 71. doi: 10.1186/1465-9921-10-71.
Marín, J. M., Ciudad, M., Moya, V., Carrizo, S., Bello, S., Piras, B., et al. (2014). Airflow reversibility and long-term outcomes in patients with COPD without comorbidities. Respir Med, 108(8), 1180–8. doi: 10.1016/j.rmed.2014.05.006.
Tashkin, D. P., Celli, B., Decramer, M., Liu, D., Burkhart, D., Cassino, C., & Kesten, S. (2008). Bronchodilator responsiveness in patients with COPD. Eur Respir J, 31, 742–750. doi: 10.1183/09031936.00129607.
Vandevoorde, J., Verbanck, S., Schuermans, D., Kartounian, J., & Vincken, W. (2005). FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest, 127(5), 1560. doi: 10.1378/chest.127.5.1560.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
